C12N 5/0665
Blood-borne mesenchymal stem cells
Official title: {Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood}
C12N5/0665 (Blood-borne mesenchymal stem cells) appears on 216 US grants and 528 published applications in this corpus.
Search patents in C12N- Granted patents
- 216
- Published applications
- 528
- Assignees
- 305
- Inventors
- 946
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 3 |
| 2005 | 1 | 6 |
| 2006 | 1 | 0 |
| 2007 | 1 | 7 |
| 2008 | 0 | 7 |
| 2009 | 2 | 5 |
| 2010 | 3 | 17 |
| 2011 | 1 | 15 |
| 2012 | 5 | 13 |
| 2013 | 3 | 27 |
| 2014 | 11 | 25 |
| 2015 | 11 | 25 |
| 2016 | 11 | 25 |
| 2017 | 13 | 27 |
| 2018 | 13 | 27 |
| 2019 | 18 | 49 |
| 2020 | 16 | 36 |
| 2021 | 16 | 34 |
| 2022 | 16 | 44 |
| 2023 | 15 | 42 |
| 2024 | 18 | 35 |
| 2025 | 17 | 28 |
| 2026 | 16 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Suppression of diabetes using exosomes from stem cell programmed myeloid cells22 Sep 2026US 12,741,015 B2Creative Medical Technologies, Inc.
- Cell therapeutic agent for cancer treatment and combination therapy with same15 Sep 2026US 12,735,680 B2Cell & Brain Co., Ltd
- Immunotherapy method of targeted chemokine and cytokine delivery by mesenchymal stem cell8 Sep 2026US 12,729,372 B2Changen Therapeutics (Shanghai) Co., Ltd.
- Method for isolating and culturing cord blood stem cells expressing GDF-3 at high level, and use of GDF-31 Sep 2026US 12,723,065 B2PRIMORIS THERAPEUTICS Co., Ltd.
- Stem cell and tissue cultures and their products11 Aug 2026US 12,703,855 B2Stem Cell Reserve LP
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Cells expressing parathyroid hormone 1 receptor and uses thereof17 Sep 2026US 2026/0275277 A1Tithon Biotech Inc.
- Extracellular Vesicles (EVs) Derived from Mesenchymal Stromal Cells and Method for Obtaining Said EVs3 Sep 2026US 2026/0258366 A1Exo Biologics SA
- Process for preparation of human umbilical cord blood plasma and culture media for tissue regeneration27 Aug 2026US 2026/0250637 A1Iceta - Instituto De CiêNcias, Tecnologias E Agroambiente Da Universidade Do Porto
Most cited
By later US patents
- Human mesenchymal stem cells from peripheral blood221US 6,261,549 B1Osiris Therapeutics, Inc. · 2001
- Blood-borne mesenchymal cells128US 5,654,186 AThe Picower Institute for Medical Research · 1997
- Purified populations of stem cells89US 6,852,533 B1Cornell Research Foundation, Inc. · 2005
- Blood-borne mesenchymal cells52US 5,846,796 AThe Picower Institute for Medical Research · 1998
- Stem cells bearing an FGF receptor on the cell surface46US 6,767,737 B1New York University · 2004